Drug Hints at Benefit for Long COVID Fatigue in Small Trial

(MedPage Today) -- An investigational therapy for long COVID failed to improve measures of mitochondrial function in a small randomized study, but the oral drug did show potential for easing patients' fatigue. Four weeks of treatment with the...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news